Drug-induced prolongation of the QT interval: why the regulatory concern?
Shah
Rashmi R
RR
Medicines Control Agency, Market Towers, 1 Nine Elms Lane, Vauxhall, London, UK.
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D017408:Guidelines as Topic; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D010597:Pharmacogenetics; D016171:Torsades de Pointes / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents